发明名称 Compound capable of binding S1P receptor and pharmaceutical use thereof
摘要 Disclosed is a compound represented by formula (I-S-7a) wherein: ring A represents a C5-12 monocyclic or bicyclic carbocyclic group or a 5- to 12-membered monocyclic or bicyclic heterocyclic group which contain 1 to 3 hetero atoms selected from an oxygen atom, a nitrogen atom and a sulfur atom; X represents a divalent group having 1 to 8 atoms in its main chain which contains 1 to 4 functional groups selected from C1- alkylene, C1-8 alkylene substituted with 1 to 3 halogen atoms or methyl, C2-8 alkenylene, C2-8 alkylene substituted with 1 to 3 halogen atoms or methyl, a nitrogen atom, a nitrogen atom substituted with methyl, -CO-, -O-, -S-, C3-6 cycloalkylene, C3-6 cycloalkylene substituted with 1 to 3 halogen atoms or methyl, phenylene, and phenylene substituted with 1 to 3 halogen atoms and wherein the rest of the substituents are disclosed within the specification. Also disclosed is the use of the above compound in the manufacture of a medicament for preventing and/or treating a disease related to EDG-1 and/or EDG-6.
申请公布号 NZ545805(A) 申请公布日期 2009.12.24
申请号 NZ20040545805 申请日期 2004.08.27
申请人 ONO PHARMACEUTICAL CO., LTD. 发明人 NAKADE, SHINJI;MIZUNO, HIROTAKA;ONO, TAKEJI;MINAMI, MASASHI;SAGA, HIROSHI;HAGIYA, HIROSHI;KOMIYA, TAKAKI;HABASHITA, HIROMU;KURATA, HARUTO;OHTSUKI, KAZUHIRO;KUSUMI, KENSUKE
分类号 C07C229/14;A61K;A61K31/11;A61K31/135;A61K31/197;A61K31/198;A61K31/222;A61K31/27;A61K31/277;A61K31/397;A61K31/472;A61K45/00;A61P37/06;A61P37/08;A61P43/00;C07C229/22;C07C229/36;C07C233/47;C07C255/16;C07C255/41;C07C271/22;C07D205/04;C07D211/04;C07D217/04;C07D405/06 主分类号 C07C229/14
代理机构 代理人
主权项
地址